Singulex Inc. presented new data at the American Heart Association Epidemiology and Prevention Council Conference highlighting research results using the company’s proprietary ultrasensitive Erenna Immunoassay System in the detection of cardiac troponin-I (cTnI). 

Allison Morgan was in pretty bad shape when the medical helicopter touched down on the rooftop helipad of the University of Alabama at Birmingham Hospital (UAB).

Three weeks after delivering her first child, Amanda began to suffer from extreme fatigue, headaches, a tight chest and stomach pain. An initial diagnosis of pneumonia changed for the worse: Amanda was experiencing heart failure. 

Interim results from The Chocolate Bar Registry conducted in the United States demonstrate that use of the Chocolate PTA balloon achieved high rates of treatment success and limb preservation in patients with peripheral arterial disease.

April 23, 2014 — Vital Images, a Toshiba Medical Systems Group company, is experiencing a significant increased demand for its VitreaView universal viewer as healthcare leaders seek opportunities to meet Stage 2 Meaningful Use requirements, connect physicians and patients to images and integrate imaging into their EMRs (electronic medical records), HIEs (health information exchanges) and EHRs (electronic health records).

April 23, 2014 — The PROCEED II heart transplant U.S. Food and Drug Administration (FDA) pivotal trial results using the Organ Care System (OCS) Heart platform were announced at the International Society for Heart and Lung Transplantation (ISHLT) 34th annual meeting and scientific sessions in San Diego.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now